Anjarium Biosciences AG is a biotechnology company headquartered in Wädenswil, Switzerland that was founded in 2016 by Joël de Beer. The company aims to mimic native intercellular communication pathways in order to generate a novel class of bioinspired nanomedicines to deliver therapeutics precisely, efficiently and safely deliver to several disease targets throughout the body.
The Hybridosome platform is a proprietary engineering approach that transforms extracellular vesicles from natural cell to cell molecular message carriers to drug carriers by the addition of therapeutic and diagnostic cargoes into the lumen and modifications to the vesicle surface for added specificity and better biodistribution.
Exosomes, nature's drug delivery fleet
Documentaries, videos and podcasts